𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Annexin 1: Differential expression in tumor and mast cells in human larynx cancer

✍ Scribed by Rosana Silistino-Souza; Flávia C. Rodrigues-Lisoni; Patricia M. Cury; José V. Maniglia; Luis S. Raposo; Eloiza H. Tajara; Helen C. Christian; Sonia M. Oliani


Publisher
John Wiley and Sons
Year
2007
Tongue
French
Weight
455 KB
Volume
120
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Annexin 1 protein (ANXA1) expression was evaluated in tumor and mast cells in human larynx cancer and control epithelium. The effect of the exogenous ANXA1 (peptide Ac 2‐26) was also examined during the cellular growth of the Hep‐2 human larynx epidermoid carcinoma cell line. This peptide inhibited the proliferation of the Hep‐2 cells within 144 hr. In surgical tissue specimens from 20 patients with larynx cancer, ultrastructural immunocytochemistry analysis showed in vivo down‐regulation of ANXA1 expression in the tumor and increased in mast cells and Hep‐2 cells treated with peptide Ac2‐26. Combined in vivo and in vitro analysis demonstrated that ANXA1 plays a regulatory role in laryngeal cancer cell growth. We believe that a better understanding of the regulatory mechanisms of ANXA1 in tumor and mast cells may lead to future biological targets for the therapeutic intervention of human larynx cancer. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Identification of differentially express
✍ Rulin Zhang; Tammy-Lynn Tremblay; Angela Mcdermid; Pierre Thibault; Danica Stani 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

## Abstract An in‐frame deletion of 801 bp in exons 2–7 (type III mutation) of the epidermal growth factor receptor (EGFR) is detected at high incidence in primary glioblastoma tumors. A proteomic approach was used to generate differential protein expression maps of fetal human astrocytes (FHA), hu

Galectin-1 expression in cancer-associat
✍ Eun-Jung Jung; Hyeong-Gon Moon; Bok Im Cho; Chi-Young Jeong; Young-Tae Joo; Youn 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 333 KB

## Abstract Understanding the molecular background of breast cancer biology is critical in developing new biomarkers for earlier diagnosis and more optimized treatment. We performed a proteomic analysis of human breast carcinoma tissues to investigate the tumor‐specific protein expression in breast

Expression of Bcl-2 by human bone marrow
✍ Cerver�, Carlos; Escribano, Luis; San Miguel, Jes�s F.; D�az-Agust�n, Beatriz; B 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 2 views

Bcl-2 protein plays a major role in the prevention of programmed cell death of differentiating cells. In the present study, the expression of cytoplasmic bcl-2 by human Bone Marrow Mast Cells (BMMC) from both normal and pathological bone marrow samples was examined. A total of 35 subjects correspond

p53 regulates FAK expression in human tu
✍ Vita M. Golubovskaya; Richard Finch; Frederick Kweh; Nicole A. Massoll; Martha C 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB

## Abstract Attenuation of the p53 protein is one of the most common abnormalities in human tumors. Another important marker of tumorigenesis is focal adhesion kinase (FAK), a 125‐kDa tyrosine kinase that is overexpressed at the mRNA and protein levels in a variety of human tumors. FAK is a critica

PAX6 methylation and ectopic expression
✍ Carol E. Salem; Isabel D.C. Markl; Christina M. Bender; Felicidad A. Gonzales; P 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 162 KB

The mechanisms underlying the de novo methylation of CpG islands in human cancer remain almost completely unknown. We used a methylation-sensitive arbitrarily primed polymerase chain reaction (Ms AP-PCR) technique to scan genomic DNA for differential methylation patterns and identified a 550 bp band